|Articles|December 1, 2012

Kawasaki disease

Some recent studies show the significant effects of Kawasaki disease on coronary arteries. Researchers all agree on the urgent need for early diagnosis and improved treatment therapies.

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Kawasaki disease

Related Content

Journal Club: Small renal stones can be managed conservatively

Doxecitine/doxribtimine cuts mortality risk in early-onset TK2d, new data show

Recognizing and managing allergic skin conditions across pediatric populations

Journal Club: Ultrasound is not reliable for diagnosing ankle fractures

Vosoritide data support planned FDA submission for hypochondroplasia

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Chronicity, Symptom Variability, and Treatment Expectations in Pediatric Functional Constipation and IBS-C

FDA issues Warning Letter to SNOO Smart Sleeper maker over unauthorized sleep sacks, hospital bundle, and quality system failures

Doxecitine/doxribtimine cuts mortality risk in early-onset TK2d, new data show

Vosoritide data support planned FDA submission for hypochondroplasia

Recognizing and managing allergic skin conditions across pediatric populations